Project Grant HT94252310240
Award Date
6/1/23
Completion Date
5/31/26
Dollars Obligated
$809K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Augusta, GA 30912, USA
Similar Awards
The Defense Health Agency awarded Augusta University Research Institute, Inc. a $1,140,960 Project Grant under the Military Medical Research and Development program to investigate androgen deprivation therapy-mediated cardiovascular disease and vascular aging in men with prostate cancer. The grant aims to study racial differences and the role of NAD+ in these conditions. The four-year award runs from February 23, 2023 through February 22, 2027 and will be performed in Augusta, Georgia. As the...
The Department of the Army Medical Command awarded a $1,155,000 Project Grant to Augusta University Research Institute, Inc. under the Military Medical Research and Development program. The grant will fund research from June 2022 to May 2025 to sensitize prostate cancer to ferropotosis-based therapy. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award supports the program's goal by...
The Department of the Army Medical Command awarded Augusta University Research Institute, Inc. a $154,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2024. The grant funds research investigating neurofibromin as a novel regulator of adipocyte maturation and function. Neurofibromin plays an important role in cell growth and differentiation, and this project will advance understanding of its...
This Project Grant award of $769,134.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Augusta University Research Institute, Inc. (AURI) to investigate the role of CXC chemokine ligand 8 in modulating cadmium-induced prostate carcinogenesis. The grant period runs from August 1, 2023 to July 31, 2026. AURI is a non-profit organization and subsidiary of the Board of Regents of the University System of Georgia, which has...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $847,875.00 to the Rector & Visitors of the University of Virginia to conduct research on "Targeting Schwann Cell-Tumor Microenvironment Interactions in Neurofibroma Development". The research aims to advance understanding of the biological mechanisms underlying neurofibromas, with the goal of transforming healthcare for...
This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an...
The Department of Defense's Defense Health Agency awarded a $685,778 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Georgia Research Foundation, Inc. This federal grant, titled "Endoplasmic Reticulum-Targeted Radiodynamic Therapy for the Treatment of Lung Cancer," will fund research from July 2024 through July 2027. The University of Georgia Research Foundation is the prime recipient and will collaborate with Emory...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,331,869.00 to Emory University to conduct research on "Therapeutic Targeting of Aurora Kinase A in Lethal Prostate Cancer Using a Novel Inhibitor". The three-year project aims to investigate medical solutions for the battlefield through innovative biomedical research. Emory University is the prime awardee, and they have subcontracted a portion of...